In vitro and in vivo study of the effects of enrofloxacin on hepatic cytochrome P-450. Potential for drug interactions.

Vet Hum Toxicol

Institute for Comparative and Environmental Toxicology, Cornell University, Ithaca, NY 14853, USA.

Published: August 1996

Enrofloxacin (EF; BAYTRIL, Miles) was the first fluoroquinolone antimicrobial to be used in veterinary medicine in the US. In humans, fluoroquinolones hinder the metabolism of other clinically important drugs through inhibition of hepatic cytochrome P-450's (P450). Similar interactions are suspected in animals. In this study, we characterized the ability of EF to modify the enzymatic activity of the P450 IA and IIB families. In an in vitro experiment, the inhibition of P450 reductase by EF was assessed by measuring the NADPH-cytochrome c reductase activity, and the inhibition of P450IA1, IA2 and IIB by 0.25, 0.5 and 1.0 mM EF was studied, respectively, by measuring the ethoxy (EROD), methoxy (MROD) and pentoxy (PROD) O-dealkylation activities in rat liver microsomes. NADPH-cytochrome c reductase was not affected. Enrofloxacin induced a strong, concentration-dependent inhibition of P450IA1 and IA2. In an in vivo experiment, the effects of 5 administrations of 5 (EF5), 25 (EF25) or 100 (EF100) mg/kg/d were assessed in rats. The liver cytochrome b5 and total P450 content was assayed by spectrophotometric measurements; P450IA and P450IIB isozyme contents were evaluated by immunoblotting with isozyme specific monoclonal antibodies, and by measuring MROD, EROD and PROD activities. A slight induction of P450IIB1 and IIB2 expression and activity (140% of controls) was only present after EF5 treatment. We concluded that EF directly inhibits P450IA1 and IA2 and advise caution when drugs metabolized extensively by these P450 isozymes are administered in association with EF. The slight stimulation of the P450IIB subfamily is not a concern at the recommended therapeutic dose of 5 mg EF/kg.

Download full-text PDF

Source

Publication Analysis

Top Keywords

p450ia1 ia2
12
hepatic cytochrome
8
nadph-cytochrome reductase
8
inhibition p450ia1
8
p450
5
vitro vivo
4
vivo study
4
study effects
4
effects enrofloxacin
4
enrofloxacin hepatic
4

Similar Publications

In vitro and in vivo study of the effects of enrofloxacin on hepatic cytochrome P-450. Potential for drug interactions.

Vet Hum Toxicol

August 1996

Institute for Comparative and Environmental Toxicology, Cornell University, Ithaca, NY 14853, USA.

Enrofloxacin (EF; BAYTRIL, Miles) was the first fluoroquinolone antimicrobial to be used in veterinary medicine in the US. In humans, fluoroquinolones hinder the metabolism of other clinically important drugs through inhibition of hepatic cytochrome P-450's (P450). Similar interactions are suspected in animals.

View Article and Find Full Text PDF

The effect of inhalation of side-stream cigarette smoke on the hepatic microsomal cytochrome P450 was investigated Rats were placed in a chamber of 0.1 m3 in volume, in which cigarettes were burned at the rate of 1, 3, or 5 cigarettes per h, 8 h/day for 5 days. Cytochrome P450 and NADPH-cytochrome c reductase showed no significant changes; however, cytochrome b5 increased significantly.

View Article and Find Full Text PDF

Male F344 rats were treated with lead nitrate and changes in the expression and induction of P450IA subfamily enzymes and a placental form of glutathione-S-transferase (GST-P) in the liver were assessed by means of a bacterial mutation test, immunoblotting with a monoclonal antibody reactive to P450IA1/IA2 and anti-GST-P sera and Northern blotting with P450IA2 cDNA as a probe. Treatment of rats with lead nitrate (20, 50 or 100 mumol/kg body wt) decreased P450IA2 mRNA and protein in the liver in the dose-dependent fashion and also decreased the microsomal activity for P450IA2-dependent mutagenization of aromatic amines. Pretreatment of rats with lead nitrate suppressed the inductions of both P450IA2 mRNA and protein by an inducer of P450IA subfamily enzymes in the liver.

View Article and Find Full Text PDF

The biotransformation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) and the protein binding of PhIP and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) was studied using microsomes from PCB-pretreated or untreated male rats of the strains, Wistar, Fischer and Sprague-Dawley. The microsomal monooxygenases, P450IA1 and IA2, which are important for the biotransformation of heterocyclic amines, were quantified by immunoblots. The two metabolites detected, 2-amino-1-methyl-6-(4'-hydroxyphenyl)imidazo[4,5-b]pyridine (4'OH-PhIP) and 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N2-OH-PhIP) were formed in similar amounts whereas no minor metabolites were found in our highly sensitive radiochemical assay.

View Article and Find Full Text PDF

[Cytochromes P450: toxicologic importance of determination of levels].

Vet Med (Praha)

April 1994

Výzkumný ústav veerinárního lékarství, Brno.

Drug-metabolizing enzymes, especially cytochrome P450-dependent monooxygenases, are involved in the metabolic activation of the majority of xenobiotics and in the production of oxygen radicals. The most significant are cytochromes P450IA1 and IA2, but also P450IIB, IIE and IIIA are involved. Various classes of xenobiotics induce levels of distinct P450 forms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!